Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Email

Medical Radiation and Cancer Risk: Assessing the Price of Progress - Amy Berrington de González, D. Phil.

Dr. Amy Berrington de González and colleagues in the Radiation Epidemiology Branch conducted the first study to directly assess the cancer risks after CT scans in a historical cohort study of 200,000 children in the U.K. She discusses the first results from this study and also presents risk projections for the number of future cancers in the U.S. that may be related to diagnostic imaging in children and adults if use continues at current levels. Dr. Berrington de González also describes work that she has conducted that assesses the balance of the potential benefits against the radiation-related cancer risks for these emerging technologies. 

Medical Radiation and Cancer Risk: Assessing the Price of Progress - Amy Berrington de González, D. Phil.

Dr. Amy Berrington de González and colleagues in the Radiation Epidemiology Branch conducted the first study to directly assess the cancer risks after CT scans in a historical cohort study of 200,000 children in the U.K. She discusses the first results from this study and also presents risk projections for the number of future cancers in the U.S. that may be related to diagnostic imaging in children and adults if use continues at current levels. Dr. Berrington de González also describes work that she has conducted that assesses the balance of the potential benefits against the radiation-related cancer risks for these emerging technologies.
 

Email